Diabetes remission associated with optimized treatment of hidradenitis suppurativa

Nessr Abu Rached; Johannes W Dietrich; Lennart Ocker; Daniel R Quast; Eggert Stockfleth; Falk G Bechara

doi:10.1111/ddg.15490

Diabetes remission associated with optimized treatment of hidradenitis suppurativa

J Dtsch Dermatol Ges. 2024 Oct;22(10):1427-1429. doi: 10.1111/ddg.15490. Epub 2024 Aug 6.

Authors

Nessr Abu Rached^{1

2}, Johannes W Dietrich^{3

4

5

6}, Lennart Ocker^{1

2}, Daniel R Quast^{3

4

6}, Eggert Stockfleth^{1

2}, Falk G Bechara^{1

2}

Affiliations

¹ International Centre for Hidradenitis suppurativa/Acne inversa (ICH), Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.
² Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.
³ Diabetes, Endocrinology and Metabolism Section, Department of Internal Medicine I, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
⁴ Diabetes Centre Bochum-Hattingen, St. Elisabeth-Hospital Blankenstein, Hattingen, Germany.
⁵ Centre for Rare Endocrine Diseases, Ruhr Centre for Rare Diseases (CeSER), Ruhr University Bochum and Witten/Herdecke University, Bochum, Germany.
⁶ Centre for Diabetes Technology, Catholic Hospitals Bochum, Bochum, Germany.

PMID: 39106221
DOI: 10.1111/ddg.15490

No abstract available

Keywords: Diabetes mellitus; HS; acne inversa; hidradenitis suppurativa; insulin resistance; metabolic syndrome.

Publication types

Letter
Case Reports

MeSH terms

Adult
Diabetes Mellitus, Type 2
Female
Hidradenitis Suppurativa* / therapy
Humans
Hypoglycemic Agents / therapeutic use
Male
Remission Induction
Treatment Outcome

Substances

Hypoglycemic Agents